These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 30117016

  • 21. MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/β-Catenin Signaling.
    Chen X, Jia C, Jia C, Jin X, Gu X.
    Cell Physiol Biochem; 2018; 48(2):815-826. PubMed ID: 30032142
    [Abstract] [Full Text] [Related]

  • 22. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.
    Yin L, Liu S, Li C, Ding S, Bi D, Niu Z, Han L, Li W, Gao D, Liu Z, Lu J.
    Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305
    [Abstract] [Full Text] [Related]

  • 23. miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma.
    Zeng A, Yin J, Li Y, Li R, Wang Z, Zhou X, Jin X, Shen F, Yan W, You Y.
    Cell Death Dis; 2018 Mar 12; 9(3):394. PubMed ID: 29531296
    [Abstract] [Full Text] [Related]

  • 24. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells.
    Wei W, Sun HH, Li N, Li HY, Li X, Li Q, Shen XH.
    Hepatobiliary Pancreat Dis Int; 2014 Oct 12; 13(5):529-38. PubMed ID: 25308364
    [Abstract] [Full Text] [Related]

  • 25. SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer.
    Zhang X, Zhao P, Wang C, Xin B.
    Biochem Biophys Res Commun; 2019 Mar 19; 510(4):508-514. PubMed ID: 30737032
    [Abstract] [Full Text] [Related]

  • 26. miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells.
    Yan HJ, Liu WS, Sun WH, Wu J, Ji M, Wang Q, Zheng X, Jiang JT, Wu CP.
    Dig Dis Sci; 2012 Dec 19; 57(12):3160-7. PubMed ID: 23001407
    [Abstract] [Full Text] [Related]

  • 27. Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression.
    Cao W, Zhao Y, Wang L, Huang X.
    Cancer Biomark; 2019 Dec 19; 25(1):101-113. PubMed ID: 30909190
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
    Xiong G, Huang H, Feng M, Yang G, Zheng S, You L, Zheng L, Hu Y, Zhang T, Zhao Y.
    J Exp Clin Cancer Res; 2018 Apr 03; 37(1):76. PubMed ID: 29615098
    [Abstract] [Full Text] [Related]

  • 31. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
    Jeon HG, Yoon CY, Yu JH, Park MJ, Lee JE, Jeong SJ, Hong SK, Byun SS, Lee SE.
    J Urol; 2011 Nov 03; 186(5):2084-93. PubMed ID: 21944112
    [Abstract] [Full Text] [Related]

  • 32. BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell.
    Chen MK, Zhou JH, Wang P, Ye YL, Liu Y, Zhou JW, Chen ZJ, Yang JK, Liao DY, Liang ZJ, Xie X, Zhou QZ, Xue KY, Guo WB, Xia M, Bao JM, Yang C, Duan HF, Wang HY, Huang ZP, Qin ZK, Liu CD.
    Aging (Albany NY); 2021 Jul 16; 13(14):18310-18330. PubMed ID: 34270461
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells.
    Zhang X, Taoka R, Liu D, Matsuoka Y, Tohi Y, Kakehi Y, Sugimoto M.
    Int J Mol Sci; 2021 Apr 15; 22(8):. PubMed ID: 33921102
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA-136-5p regulates gemcitabine resistance in pancreatic cancer via down-regulating ZNF32.
    Xu Y, Qin Y, Cui JX, Xu J.
    Eur Rev Med Pharmacol Sci; 2020 Oct 15; 24(20):10472-10482. PubMed ID: 33155203
    [Abstract] [Full Text] [Related]

  • 36. MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p/PBOV1 axis.
    Chen W, Tan X, Yang Q, Fang Z, Xu Y.
    Cell Signal; 2022 Jun 15; 94():110326. PubMed ID: 35367362
    [Abstract] [Full Text] [Related]

  • 37. circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling.
    Huo LW, Wang YF, Bai XB, Zheng HL, Wang MD.
    Mol Med; 2020 Apr 08; 26(1):29. PubMed ID: 32268875
    [Abstract] [Full Text] [Related]

  • 38. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.
    Shen Y, Pan Y, Xu L, Chen L, Liu L, Chen H, Chen Z, Meng Z.
    Tumour Biol; 2015 Jun 08; 36(6):4525-34. PubMed ID: 25722110
    [Abstract] [Full Text] [Related]

  • 39. MiR-539-5p negatively regulates migration of rMSCs induced by Bushen Huoxue decoction through targeting Wnt5a.
    Hu L, Liu Y, Wang B, Wu Z, Chen Y, Yu L, Zhu J, Shen W, Chen C, Chen D, Li G, Xu L, Luo Y.
    Int J Med Sci; 2019 Jun 08; 16(7):998-1006. PubMed ID: 31341413
    [Abstract] [Full Text] [Related]

  • 40. Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A.
    Bian WG, Zhou XN, Song S, Chen HT, Shen Y, Chen P.
    Eur Rev Med Pharmacol Sci; 2019 Jan 08; 23(2):649-659. PubMed ID: 30720173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.